Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age. - Díez-Domingo J; Sáez-Llorens X; Rodriguez-Weber MA; Epalza C; Chatterjee A; Chiu CH; Lin CY; Berry AA; Martinón-Torres F; Baquero-Artigao F; Langley JM; Ramos Amador JT; et al. (The Journal of infectious diseases, 2023)